Traphaco JSC (TRA) - Total Liabilities
Based on the latest financial reports, Traphaco JSC (TRA) has total liabilities worth ₫653.06 Billion VND (≈ $24.81 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TRA cash generation efficiency to assess how effectively this company generates cash.
Traphaco JSC - Total Liabilities Trend (2019–2025)
This chart illustrates how Traphaco JSC's total liabilities have evolved over time, based on quarterly financial data. Check TRA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Traphaco JSC Competitors by Total Liabilities
The table below lists competitors of Traphaco JSC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RumbleON Inc
NASDAQ:RMBL
|
USA | $717.00 Million |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
USA | $31.58 Million |
|
Elementos Ltd
AU:ELT
|
Australia | AU$736.16K |
|
Indonesia Fibreboard Industry PT
JK:IFII
|
Indonesia | Rp402.69 Billion |
|
Afyon Cimento Sanayi TAS
IS:AFYON
|
Turkey | TL775.19 Million |
|
Awardit AB
ST:AWRD
|
Sweden | Skr636.19 Million |
|
Daechang Forgi
KO:015230
|
Korea | ₩81.19 Billion |
|
CAPRAL LTD.
F:CBZ
|
Germany | €239.10 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Traphaco JSC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Traphaco JSC market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Traphaco JSC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Traphaco JSC (2019–2025)
The table below shows the annual total liabilities of Traphaco JSC from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₫653.06 Billion ≈ $24.81 Million |
+2.65% |
| 2024-12-31 | ₫636.21 Billion ≈ $24.17 Million |
+0.22% |
| 2023-12-31 | ₫634.85 Billion ≈ $24.12 Million |
+45.71% |
| 2022-12-31 | ₫435.71 Billion ≈ $16.55 Million |
-0.88% |
| 2021-12-31 | ₫439.57 Billion ≈ $16.70 Million |
-8.11% |
| 2020-12-31 | ₫478.38 Billion ≈ $18.18 Million |
+5.49% |
| 2019-12-31 | ₫453.48 Billion ≈ $17.23 Million |
-- |
About Traphaco JSC
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases,… Read more